Showing 381-390 of 2839 results for "".
MATV News: FDA Approves Cellfina to Treat Cellulite; miraDry to Launch miraSmooth
https://modernaesthetics.com/series/matv-news/matv-news-fda-approves-cellfina-to-treat-cellulite-miradry-to-launch-mirasmooth/33419/In this edition of MATV News, from the editors of Modern Aesthetics® magazine, we review the FDA's clearance of Cellfina to treat cellulite with no loss of benefit for up to two-years as well as the new indication for miraDry for hair removal and the launch of miraSmooth. Also in this edition, FDA aComing & Going: November/December 2022
https://modernaesthetics.com/ma-issues-index/2022-nov-dec/coming-going-novemberdecember-2022/35236/Combining Thread Lifting and Filler Injections
https://modernaesthetics.com/topics/injectables/combining-thread-lifting-and-filler-injections/35411/Coming & Going: February 2023
https://modernaesthetics.com/topics/practice-development/coming-going-february-2023/35254/Consumers Believe in Price Transparency. So Should You!
https://modernaesthetics.com/ma-issues-index/2016-sept-oct/consumers-believe-in-price-transparency-so-should-you/34351/While some core specialists worry about losing patients to less expensive competitors, one expert sees price transparency as a benefit.Non-prescription Skincare for Skin of Color: Tips on Product Recommendation
https://modernaesthetics.com/topics/skincare/non-prescription-skincare-for-skin-of-color-tips-on-product-recommendation/33953/Patients with skin of color can select from a growing array of skincare products to meet their needs.How an Email Database Can Power Your Practice
https://modernaesthetics.com/topics/practice-development/how-an-email-database-can-power-your-practice/33958/Facebook and Google advertising aren't cheap. And they aren't necessarily attuned to the needs of aesthetics practices. So what should you do?Ch-ch-ch-ch-changes
https://modernaesthetics.com/ma-issues-index/2024-jan-feb/ch-ch-ch-ch-changes/35338/“For me, medicine is not a career choice. It is a life choice.”Understanding and Treating Estrogen Deficient Skin: A Panel Discussion About an Entirely New Category of Skin Care
https://modernaesthetics.com/ma-supplements/2019-june-may-supplement/understanding-and-treating-estrogen-deficient-skin-a-panel-discussion-about-an-entirely-new-category-of-skin-care/33964/Biopelle, Inc. has launched Emepelle, the first and only clinically proven skin care line that safely and effectively helps address estrogen deficient skin (EDS) with revolutionary, new MEP Technology™. To coincide with the launch, a panel of leading dermatologists convened recently to discuss the pThree Ways: Building a Brand: What are the Most important components?
https://modernaesthetics.com/topics/practice-development/building-a-brand-what-are-the-most-important-components/34005/Expert tips for cultivating and growing a brand for your aesthetic practice.